期刊文献+

药房中药饮片使用情况探析

Analysis on the Use of Chinese Herbal Pieces in Pharmacies
下载PDF
导出
摘要 目的分析我院2014年1月至2016年12月中药饮片使用情况。方法采用回顾性方法,对我院使用量较大的前36味中药饮片和出现频率前十位的方剂进行统计、分析。结果方药的应用中,四君子汤(《和剂局方》)的加减应用在处方中出现的频率最高,其次是补中益气汤(《脾胃论》)。结论本院使用的中药主要以《中国药典》(2010版)为主,中医医师的用药特点是多以补气血为主,治疗时以扶正固本、补气血、健脾胃为主。 Objective To analyze the use of Chinese Herbal Pieces in our hospital from January 2014 to December 2016.Methods By retrospective method,the 36 pieces of traditional Chinese medicine and the top ten prescriptions were analyzed.Results In the application of prescriptions,the frequency of addition and subtraction of Sijunzi Decoction is the highest.The second is Buzhong Yiqi Decoction(on spleen and stomach).Conclusion Chinese Pharmacopoeia(2010 Edition)is the main traditional Chinese medicine used in our hospital.The characteristics of traditional Chinese medicine doctors are mainly to replenish qi and blood,and the treatment is mainly to strengthen the body,replenish qi and blood,and strengthen the spleen and stomach.
作者 邓霁玲 蔺继海 DENG Ji-ling;LIN Ji-hai(Wuwei Traditional Chinese Medicine Hospital,Wuwei,Gansu 733000)
出处 《智慧健康》 2020年第8期179-181,共3页 Smart Healthcare
关键词 中药饮片 方剂 使用情况 分析 Chinese herbal pieces Prescriptions Usage situation Analysis
  • 相关文献

参考文献8

二级参考文献31

  • 1肖扬,张洹,何冬梅.hTR反义寡核苷酸对急性白血病原代细胞端粒酶活性及凋亡的影响[J].广东医学,2004,25(12):1379-1381. 被引量:2
  • 2肖扬,张宏斌,张洹.急性白血病组织中端粒酶活性与p170共同表达及其临床意义[J].肿瘤防治杂志,2005,12(7):522-524. 被引量:1
  • 3张参军,康开彪,李文艳.王自立主任医师运用补中益气汤经验[J].甘肃中医,2005,18(10):19-19. 被引量:4
  • 4贺庆,朱恩圆,王峥涛,侴桂新,徐珞珊,胡之璧.党参化学成分的研究[J].中国药学杂志,2006,41(1):10-12. 被引量:78
  • 5Lin q'T, Letsolo BT, Jones RE, et al. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis[J]. Blood, 2010 Sep 16, 116(11) : 1899-907.
  • 6White DL.Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance[J]. Leuk-Lymphoma, 2008, 49(6): 1022-3.
  • 7Ghaffari S H, Shayan Asl-N, Jamialahmadi et al. Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival[J]. Ann-Oncol, 2008, 19(11): 1927-34.
  • 8Wang, Y, Fang M, Sun X, et al. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival. Int-J-Lab-Hematol [J]. 2010, 32 (2) : 230-8.
  • 9Novotny L, Rauko P, Schott H. Cytotoxicity and antileukaemic activity of new duplexes linking 3-C-ethynylcytidine and 5-fluorodeoxyuridine.Anticancer-Res[J]. 2010 Dec; 30(12) : 4891-8.
  • 10Abramkin SA; Jungwirth U, Valiahdi SM et al. {(1R, 2R, 4R)-4- methyl-l, 2-eycloh exanediamine} oxalatoplatinum (II): a novel enantiomerieally pure oxaliplatin derivative showing improved anti-cancer activity in vivo [J]. J-Med-Chem. 2010 Oct 28; 53 (20): 7356-64.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部